Skip to main content
. 2020 Sep 14;13(9):245. doi: 10.3390/ph13090245

Figure 1.

Figure 1

Schematic representation of the first and second generation FDA-approved ADCs: Mylotarg®, Adcetris®, Kadcyla®, Besponsa®, Polivy® and Padcev®.